Skip to main content

Table 1 Characteristics of the sarcoidosis patients

From: T cell receptor-Vβ repertoires in lung and blood CD4+ and CD8+T cells of pulmonary sarcoidosis patients

Patient characterizations

Pulmonary function tests

Patient

HLA DRB1 type

CD4/CD8 ratio

Lymphocytes in BAL (%)

Chest X-ray stage*

VC (%)

FEV1(%)

DLco(%)

1

4, 15

17

49

I

93

100

84

2

3

11.1

25

I

76

82

 

3

1, 3

1.8

6.6

II

82

81

87

4

NA

10.3

64

I

69

63

58

5

13, 14

11.8

34

II

108

103

90

6

4, 8

8.9

32

I

90

76

73

7

4, 15

7.3

16.8

II

 

68

 

8

1, 13

14.4

14.2

I

80

79

 

9

3, 16

11.3

25.6

I

84

89

 

10

3, 15

2.2

7

I

96

107

111

11

13, 15

3.6

12.4

III

73

60

93

12

4, 15

7.2

25.6

I

119

124

111

13

15

3

50

II

85

80

 

14

4, 7

2.4

7.6

IV

65

62

55

15

4, 8

6

19

III

99

86

78

  1. NA = not analysed, VC = vital capacity (% of reference value), FEV1 = forced expiratory volume in one second, DLco = diffusing capacity of the lung for carbon monoxide. *Chest X-ray stages: I) Bilateral hilar lymphadenopathy (BHL) without pulmonary infiltrates, II) BHL with pulmonary infiltrates, III) pulmonary infiltrates without BHL, IV) fibrosis with distortions.